Cardiometabolic Effects of a Workplace Cycling Intervention

In laboratory settings, cycling workstations improve cardiometabolic risk factors. Our purpose was to quantify risk factors following a cycling intervention in the workplace.

Twenty-one office workers who sat at work ≥6 hours per day underwent baseline physiological measurements (resting blood pressure, blood lipid profile, maximum oxygen consumption [V˙O2max], body composition, and 2-h oral glucose tolerance test). Participants were randomly assigned to a 4-week intervention only group (n = 12) or a delayed intervention group (n = 9) that involved a 4-week control condition before beginning the intervention. During the intervention, participants were instructed to use the cycling device a minimum of 15 minutes per hour, which would result in a total use of ≥2 hours per day during the workday. Following the intervention, physiological measurements were repeated.

Participants averaged 1.77 (0.48) hours per day of cycling during the intervention with no changes in actigraphy-monitored noncycling physical activity. Four weeks of the workplace intervention increased V˙O2max (2.07 [0.44] to 2.17 [0.44] L·min-1, P < .01); end of V˙O2max test power output (166.3 [42.2] to 176.6 [46.1] W, P < .01); and high-density lipoprotein cholesterol (1.09 [0.17] to 1.17 [0.24] mmol·L-1, P = .04).

A stationary cycling device incorporated into a sedentary workplace for 4 weeks improves some cardiometabolic risk factors with no compensatory decrease in noncycling physical activity.